Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Resverlogix begins dosing in phase I study of apabetalone in severe renal impairment

July 22, 2016

FDA accepts Revive's IND for a phase II trial of bucillamine for cystinuria

July 7, 2016

Pfizer introduces AMPK activators

June 22, 2016

FDA approves Rayaldee for secondary hyperparathyroidism in CKD

June 21, 2016

Boehringer Ingelheim discloses aldosterone synthase inhibitors

June 20, 2016

Astellas Pharma and Kotobuki Pharmaceutical patent leucyl-cystinyl aminopeptidase antagonists

June 17, 2016

Eli Lilly and Company develops PKC inhibitors

June 3, 2016

FDA issues complete response letter for sodium zirconium cyclosilicate for hyperkalemia

May 27, 2016

Linaclotide shows preclinical potential for bladder hyperactivity

May 25, 2016

Interim phase II data for bardoxolone methyl show improvement in renal function

May 24, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...